NCT03866954View on ClinicalTrials.gov

Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal Encephalomyopathy

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

December 31, 2027

Conditions
Mitochondrial DiseasesMetabolic DiseaseInborn Errors of Metabolism
Interventions
COMBINATION_PRODUCT

EE-TP

Ecoli thymidine phoshorylase encapsulated within autologous erythrocytes

Sponsors

Collaborators (1)

Neovii Biotech
All Listed Sponsors
collaborator

Neovii Biotech

INDUSTRY

lead

St George's, University of London

OTHER